Breaking News

Cytovance, NeuroFx Enter Development and Mfg. Pact

To deliver a robust process for cell-free therapy to treat neurological conditions

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cytovance Biologics, Inc. has partnered with NeuroFx to develop and manufacture stem cell derived, cell-free therapy for neurological conditions. NeuroFx has selected Cytovance to develop a therapeutic factor concentrate platform and program to deliver a robust development and manufacturing process.   Brian Johnstone Ph.D., director of R & D at NeuroFx, said, “Recognition of the critical function of mesenchymal stem cells’ (MSC) paracrine factors has prompted investigation into...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters